Copyright
©The Author(s) 2005. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Oct 7, 2005; 11(37): 5882-5887
Published online Oct 7, 2005. doi: 10.3748/wjg.v11.i37.5882
Published online Oct 7, 2005. doi: 10.3748/wjg.v11.i37.5882
Interferon-α plus lamivudine vs lamivudine reduces breakthroughs, but does not affect sustained response in HBeAg negative chronic hepatitis B
Michalis Economou, Spilios Manolakopoulos, Sotiris Bethanis, Dimitrios Tzourmakliotis, Department of Gastroenterology, Polyclinic General Hospital, Athens, Greece
Michalis Economou, Spyros Filis, Epameinondas V Tsianos, Hepato-Gastroenterology Unit, Department of Internal Medicine, University of Ioannina School of Medicine, Ioannina, Greece
Thomas A Trikalinos, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece
Alec Avgerinos, 2nd Department of Gastroenterology, “Evangelismos” General Hospital, Athens, Greece
Alec Avgerinos, Sotiris Raptis, 2nd Department of Internal Medicine, Propaedeutic, Athens University, Athens, Greece
Author contributions: All authors contributed equally to the work.
Correspondence to: Michalis Economou, MD, Department of Internal Medicine, University of Ioannina School of Medicine, University Campus, Ioannina 45110, Greece. meconom@cc.uoi.gr
Telephone: +30-26510-79501 Fax: +30-26510-99736
Received: December 4, 2004
Revised: January 1, 2005
Accepted: January 5, 2005
Published online: October 7, 2005
Revised: January 1, 2005
Accepted: January 5, 2005
Published online: October 7, 2005
Core Tip